September 12, 2026 · Gynecologic oncology reports · DOI: 10.1016/j.gore.2026.102201

Markedly elevated alpha-fetoprotein leading to the diagnosis of high-grade endometrial carcinoma during hepatocellular carcinoma surveillance

Listen to this summary

The authors investigate the potential of alpha-fetoprotein (AFP) as a marker for aggressive histologic variants of endometrial carcinoma, particularly in patients undergoing surveillance for hepatocellular carcinoma (HCC). They present a case of a 70-year-old woman whose significantly elevated AFP levels led to the diagnosis of high-grade endometrial carcinoma, despite no evidence of HCC, underscoring the need to consider non-hepatic causes of AFP elevation in clinical practice.

Jayati Anand, Alicia Youssef, Lawrence Hsu Lin, Niloofar O Karbasian, Annekathryn Goodman, Michelle Lai

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play